A novel and potent TRPV4 channel agonist. GSK1016790A induced Ca2+ influx in mouse and human TRPV4 expressing HEK cells (EC50 values of 18 and 2.1 nM, respectively), and evoked a dose-dependent activation of TRPV4 whole-cell currents at concentrations above 1 nM. It is 300-fold more potent than 4alpha-PDD and is a valuable tool for investigating the role of TRPV4 in physiological processes.
* VAT and and shipping costs not included. Errors and price changes excepted